Nifty

:

10787.25

Sensex

:

36360.71

-53.40 (-0.49%)
-203.17 (-0.56%)

Login

Nifty
Sensex

:
:

10787.25
36360.71

-53.40 (-0.49%)
-203.17 (-0.56%)

Orchid Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 524372 | NSE: ORCHIDPHAR

Watchlist

NSE BSE

Not traded in the last 30 days

Open
High
Low
Previous Close

N/A
N/A
N/A
N/A

Volume
Traded Value (lacs)
52 Week High
52 Week Low

N/A
N/A
N/A
N/A

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

46.71
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,943.10
N/A
-0.07

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

10 Years
5 Years
3 Years

-5.96
-
-9.85

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-17.82
-
-33.75

PAT CAGR (%)

10 Years
5 Years
3 Years

21.15
-
9.01

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.83
0.84
0.09

EV:EBITDA (Average)

8 Years
5 Years
3 Years

41.22
58.12
87.33

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 135.77 130.65 3.92% 162.07 155.78 4.04% 148.45 144.24 2.92% 142.48 209.34 -31.94%
Expenses 145.16 144.90 0.18% 169.77 148.02 14.69% 135.95 130.65 4.06% 145.72 185.57 -21.47%
EBITDA -9.39 -14.25 - -7.70 7.77 - 12.50 13.59 -8.02% -3.24 23.77 -
EBIDTM -6.91% -10.91% -4.75% 4.99% 8.42% 9.42% -2.27% 11.35%
Other Income 5.15 4.27 20.61% 4.48 1.42 215.49% 1.90 8.36 -77.27% 6.28 4.72 33.05%
Interest 0.00 13.55 -100.00% 0.00 79.14 -100.00% 0.03 76.18 -99.96% 0.00 75.45 -100.00%
Depreciation 31.36 32.79 -4.36% 31.34 32.57 -3.78% 32.84 33.48 -1.91% 32.96 33.64 -2.02%
PBT -35.60 -46.00 - -13.44 -102.52 - -18.47 -87.70 - -23.13 -80.60 -
Tax 0.00 0.01 -100.00% 0.00 -10.15 - 0.00 -10.47 - -0.01 -10.27 -
PAT -35.60 -46.01 - -13.44 -92.37 - -18.47 -77.23 - -23.13 -70.34 -
PATM -26.22% -35.22% -8.30% -59.30% -12.44% -53.55% -16.23% -33.60%
EPS -4.00 -5.17 - -1.51 -10.38 - -2.08 -8.68 - -2.60 -7.91 -

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 135.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 147.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA -12.23 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM -9.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 5.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 31.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -38.45 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -38.45 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM -28.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS -4.32 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Net Sales 588.77 644.17 755.36 879.34 1,736.19 1,906.58 1,736.33 1,663.35 2,265.14 1,191.44 1,238.92 Net Sales Growth -8.01% -14.72% -14.10% -49.35% -8.94% 9.81% 4.39% -26.57% 90.12% -3.83% Cost Of Goods Sold 276.92 330.87 367.46 419.31 781.33 958.27 785.86 787.96 731.71 472.97 397.26 Gross Profit 311.85 313.30 387.89 460.03 954.86 948.32 950.47 875.39 1,533.42 718.47 841.66 GP Margin 52.97% 48.64% 51.35% 52.32% 55.00% 49.74% 54.74% 52.63% 67.70% 60.30% 67.93% Total Expenditure 596.60 621.96 663.28 705.28 1,416.33 1,776.74 1,470.46 1,323.11 1,422.55 1,033.28 894.09 Power & Fuel Cost - 50.69 54.33 55.28 102.19 121.72 85.72 72.54 66.44 73.45 69.58 % Of Sales - 7.87% 7.19% 6.29% 5.89% 6.38% 4.94% 4.36% 2.93% 6.16% 5.62% Employee Cost - 82.39 75.44 82.63 185.79 237.05 154.65 141.38 159.29 122.88 99.90 % Of Sales - 12.79% 9.99% 9.40% 10.70% 12.43% 8.91% 8.50% 7.03% 10.31% 8.06% Manufacturing Exp. - 63.08 85.12 91.48 182.20 223.51 190.13 140.34 169.00 150.14 158.80 % Of Sales - 9.79% 11.27% 10.40% 10.49% 11.72% 10.95% 8.44% 7.46% 12.60% 12.82% General & Admin Exp. - 38.03 38.42 28.04 88.13 92.49 75.05 87.77 115.14 69.03 66.39 % Of Sales - 5.90% 5.09% 3.19% 5.08% 4.85% 4.32% 5.28% 5.08% 5.79% 5.36% Selling & Distn. Exp. - 14.62 35.43 21.35 48.59 48.33 54.14 47.00 42.24 47.00 45.57 % Of Sales - 2.27% 4.69% 2.43% 2.80% 2.53% 3.12% 2.83% 1.86% 3.94% 3.68% Miscellaneous Exp. - 42.28 7.07 7.19 28.11 95.37 124.91 46.12 138.72 97.81 45.57 % Of Sales - 6.56% 0.94% 0.82% 1.62% 5.00% 7.19% 2.77% 6.12% 8.21% 4.57% EBITDA -7.83 22.21 92.08 174.06 319.86 129.84 265.87 340.24 842.59 158.16 344.83 EBITDA Margin -1.33% 3.45% 12.19% 19.79% 18.42% 6.81% 15.31% 20.46% 37.20% 13.27% 27.83% Other Income 17.81 19.87 19.48 24.60 42.37 39.77 145.85 57.10 9.80 90.15 72.51 Interest 0.03 310.25 331.10 294.23 537.01 520.38 179.05 115.77 241.23 155.19 81.13 Depreciation 128.50 133.29 139.42 143.41 321.37 243.87 149.06 128.45 151.10 129.97 97.67 PBT -90.64 -401.47 -358.96 -238.98 -496.15 -594.63 83.62 153.11 460.05 -36.85 238.54 Tax -0.01 -46.19 -48.04 -17.25 -191.75 -13.30 -23.37 14.32 128.71 15.33 54.01 Tax Rate 0.01% 11.51% 9.04% 5.92% 50.09% 2.45% -29.31% 8.24% 27.98% -41.60% 22.64% PAT -90.64 -355.28 -483.63 -274.27 -191.04 -530.23 103.11 159.48 331.34 -52.17 184.54 PAT before Minority Interest -90.64 -355.28 -483.63 -274.27 -191.04 -530.23 103.11 159.48 331.34 -52.17 184.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -15.39% -55.15% -64.03% -31.19% -11.00% -27.81% 5.94% 9.59% 14.63% -4.38% 14.90% PAT Growth 0.00% - - - - - -35.35% -51.87% - - Unadjusted EPS -10.19 -39.93 -54.36 -31.51 -26.11 -75.26 14.64 22.64 47.04 -7.61 28.02

Description TTM Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Net Sales - 682.98 796.50 873.44 1,746.61 1,947.70 1,873.60 1,781.79 2,358.76 1,296.85 1,300.96 Net Sales Growth - -14.25% -8.81% -49.99% -10.32% 3.95% 5.15% -24.46% 81.88% -0.32% Cost Of Goods Sold - 350.20 393.46 400.96 779.03 990.12 876.31 868.89 795.29 547.45 441.36 Gross Profit - 332.79 403.05 472.47 967.58 957.58 997.29 912.90 1,563.47 749.40 859.61 GP Margin - 48.73% 50.60% 54.09% 55.40% 49.16% 53.23% 51.23% 66.28% 57.79% 66.08% Total Expenditure - 658.68 709.37 702.65 1,429.32 1,837.44 1,516.99 1,433.68 1,500.34 1,126.28 961.02 Power & Fuel Cost - 50.69 54.33 55.28 102.19 121.72 89.14 76.80 70.58 77.55 72.90 % Of Sales - 7.42% 6.82% 6.33% 5.85% 6.25% 4.76% 4.31% 2.99% 5.98% 5.60% Employee Cost - 86.22 80.25 86.81 193.82 252.70 176.41 164.73 174.48 137.46 117.14 % Of Sales - 12.62% 10.08% 9.94% 11.10% 12.97% 9.42% 9.25% 7.40% 10.60% 9.00% Manufacturing Exp. - 65.65 87.40 94.33 182.40 226.41 198.70 150.32 176.73 156.91 169.37 % Of Sales - 9.61% 10.97% 10.80% 10.44% 11.62% 10.61% 8.44% 7.49% 12.10% 13.02% General & Admin Exp. - 41.49 40.99 31.10 91.62 93.40 76.95 92.71 113.80 68.19 67.89 % Of Sales - 6.07% 5.15% 3.56% 5.25% 4.80% 4.11% 5.20% 4.82% 5.26% 5.22% Selling & Distn. Exp. - 22.10 45.73 27.73 51.28 55.52 63.26 55.06 44.17 50.71 50.57 % Of Sales - 3.24% 5.74% 3.17% 2.94% 2.85% 3.38% 3.09% 1.87% 3.91% 3.89% Miscellaneous Exp. - 42.34 7.21 6.44 28.97 97.57 36.21 25.17 125.30 88.00 50.57 % Of Sales - 6.20% 0.91% 0.74% 1.66% 5.01% 1.93% 1.41% 5.31% 6.79% 3.21% EBITDA - 24.30 87.13 170.79 317.29 110.26 356.61 348.11 858.42 170.57 339.94 EBITDA Margin - 3.56% 10.94% 19.55% 18.17% 5.66% 19.03% 19.54% 36.39% 13.15% 26.13% Other Income - 20.30 19.17 24.91 42.47 40.72 56.19 53.02 8.59 86.05 71.30 Interest - 310.26 331.11 294.24 537.12 522.69 179.75 116.75 242.27 156.45 82.00 Depreciation - 133.31 141.02 145.27 324.58 251.92 153.74 133.50 154.90 133.99 100.68 PBT - -398.96 -365.82 -243.82 -501.95 -623.63 79.32 150.87 469.83 -33.82 228.56 Tax - -46.19 -48.04 -17.25 -191.46 -12.52 -22.04 15.38 130.58 15.17 53.23 Tax Rate - 11.58% 8.92% 5.82% 49.27% 2.19% -29.22% 8.96% 27.79% -44.86% 23.29% PAT - -352.77 -490.49 -279.11 -196.51 -558.02 97.48 156.19 339.25 -48.99 175.34 PAT before Minority Interest - -352.77 -490.49 -279.11 -197.13 -559.99 97.48 156.19 339.25 -48.99 175.34 Minority Interest - 0.00 0.00 0.00 0.62 1.97 0.00 0.00 0.00 0.00 0.00 PAT Margin - -51.65% -61.58% -31.96% -11.25% -28.65% 5.20% 8.77% 14.38% -3.78% 13.48% PAT Growth - - - - - - -37.59% -53.96% - - Unadjusted EPS - -39.65 -55.13 -32.07 -26.88 -79.21 13.84 22.17 48.16 -7.14 26.63

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds -674.13 -263.83 171.13 439.40 488.17 488.17 1,146.31 1,134.02 979.63 670.22 Share Capital 88.96 88.96 88.96 85.26 70.45 70.45 70.44 70.44 70.44 70.44 Total Reserves -763.10 -352.80 82.17 354.14 417.71 417.71 1,075.87 1,063.58 909.19 599.77 Non-Current Liabilities 1,904.62 2,204.95 2,475.41 2,609.53 1,064.91 1,064.91 1,253.05 850.06 1,850.93 2,726.25 Secured Loans 1,893.91 2,156.78 2,377.54 2,493.95 901.78 901.78 1,074.15 604.06 1,021.76 1,695.01 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 625.36 901.74 Long Term Provisions 7.48 2.07 3.73 4.18 5.24 5.24 7.72 9.64 0.00 0.00 Current Liabilities 1,980.28 1,519.64 1,315.98 1,107.10 3,170.14 3,170.14 1,499.29 1,904.30 957.45 825.45 Trade Payables 326.85 403.68 353.09 295.85 561.67 561.67 403.97 261.50 306.48 366.54 Other Current Liabilities 958.10 476.00 285.05 112.37 1,052.40 1,052.40 406.55 993.78 291.14 362.33 Short Term Borrowings 694.29 599.52 633.62 646.64 1,524.89 1,524.89 637.88 489.86 0.00 0.00 Short Term Provisions 1.03 40.44 44.22 52.23 31.17 31.17 50.89 159.16 359.83 96.57 Total Liabilities 3,210.77 3,460.76 3,962.52 4,156.03 4,723.22 4,723.22 3,898.65 3,888.38 3,788.01 4,221.92 Net Block 1,291.28 1,401.71 1,540.36 1,697.10 2,482.81 2,482.81 1,931.34 1,595.91 1,463.41 1,866.35 Gross Block 1,563.29 2,893.25 2,893.19 2,889.70 3,659.71 3,659.71 2,918.68 2,443.99 2,184.29 2,535.59 Accumulated Depreciation 272.01 1,491.54 1,352.83 1,192.60 1,176.90 1,176.90 987.34 848.08 720.87 669.25 Non Current Assets 2,519.97 2,507.72 2,638.40 2,809.23 3,571.52 3,571.52 2,686.88 2,361.32 2,055.42 2,534.50 Capital Work in Progress 271.53 288.31 280.40 281.51 360.42 360.42 350.43 330.46 468.44 545.79 Non Current Investment 124.77 124.66 124.65 124.65 124.18 124.18 148.90 130.42 123.57 122.37 Long Term Loans & Adv. 822.41 685.17 680.99 681.85 576.08 576.08 219.66 287.75 0.00 0.00 Other Non Current Assets 9.98 7.88 12.00 24.12 28.04 28.04 36.55 16.79 0.00 0.00 Current Assets 690.80 953.03 1,324.12 1,346.79 1,151.69 1,151.69 1,211.77 1,527.07 1,732.60 1,603.83 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 184.94 197.45 210.34 242.28 500.08 500.08 623.60 580.26 402.53 743.69 Sundry Debtors 145.06 246.42 375.44 290.16 183.70 183.70 91.31 481.11 716.23 659.04 Cash & Bank 301.04 256.04 313.11 389.57 22.40 22.40 169.59 193.18 324.91 41.52 Other Current Assets 59.75 8.90 116.41 105.52 445.51 445.51 327.27 272.52 288.92 159.59 Short Term Loans & Adv. 40.31 244.22 308.82 319.26 431.67 431.67 313.59 265.03 284.72 154.50 Net Current Assets -1,289.49 -566.61 8.14 239.69 -2,018.45 -2,018.45 -287.53 -377.24 775.15 778.38 Total Assets 3,210.77 3,460.75 3,962.52 4,156.02 4,723.21 4,723.21 3,898.65 3,888.39 3,788.02 4,221.91

Description Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Shareholder's Funds -791.76 -387.67 49.04 329.39 379.99 1,132.30 1,069.24 937.66 633.80 664.98 Share Capital 88.96 88.96 88.96 85.26 70.45 70.44 70.44 70.44 70.44 65.85 Total Reserves -880.72 -476.63 -39.92 244.12 309.53 1,061.86 998.80 867.22 563.36 599.13 Non-Current Liabilities 1,904.62 2,204.95 2,475.41 2,609.35 1,064.40 1,251.94 849.66 1,864.07 2,744.32 2,085.45 Secured Loans 1,893.91 2,156.78 2,377.54 2,493.95 901.79 1,074.15 604.06 1,035.91 1,714.11 979.56 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 625.36 901.74 990.98 Long Term Provisions 7.48 2.07 3.73 4.18 5.24 7.72 9.64 0.00 0.00 0.00 Current Liabilities 2,012.51 1,540.72 1,337.62 1,122.66 3,206.03 1,551.05 1,989.41 971.83 855.83 733.80 Trade Payables 358.79 424.52 374.27 311.15 597.40 447.00 335.16 318.21 390.10 296.23 Other Current Liabilities 958.40 476.24 285.34 112.64 1,052.57 406.96 1,005.23 293.78 369.16 359.23 Short Term Borrowings 694.29 599.52 633.79 646.64 1,524.89 647.06 489.86 0.00 0.00 0.00 Short Term Provisions 1.03 40.44 44.22 52.23 31.17 50.03 159.16 359.84 96.58 78.34 Total Liabilities 3,125.37 3,358.00 3,862.07 4,061.40 4,651.04 3,938.11 3,910.23 3,773.56 4,233.95 3,484.23 Net Block 1,386.20 1,496.54 1,636.83 1,795.20 2,583.57 2,073.88 1,741.76 1,603.31 2,007.51 1,539.95 Gross Block 1,659.50 3,005.92 3,005.87 3,002.15 3,772.17 3,089.68 2,613.62 2,344.63 2,695.66 2,098.12 Accumulated Depreciation 273.30 1,509.38 1,369.04 1,206.95 1,188.60 1,015.80 871.86 741.32 688.16 558.17 Non Current Assets 2,446.42 2,478.86 2,610.87 2,783.27 3,549.62 2,684.83 2,383.94 2,072.24 2,554.21 2,160.07 Capital Work in Progress 271.53 288.31 280.40 281.51 360.42 352.25 332.29 468.92 546.70 620.12 Non Current Investment 1.07 0.96 0.81 0.81 0.95 0.81 0.81 0.00 0.00 0.00 Long Term Loans & Adv. 777.64 685.17 680.83 681.63 576.08 219.66 287.82 0.00 0.00 0.00 Other Non Current Assets 9.98 7.88 12.00 24.12 28.60 38.23 21.26 0.00 0.00 0.00 Current Assets 678.94 879.14 1,251.20 1,278.12 1,101.42 1,253.29 1,526.30 1,701.32 1,596.17 1,324.16 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.81 0.81 0.81 Inventories 193.74 211.25 241.85 251.93 506.24 668.73 617.63 422.64 768.25 649.15 Sundry Debtors 119.51 203.00 310.07 256.57 179.06 113.24 513.48 736.98 672.54 537.94 Cash & Bank 305.55 257.06 314.94 390.56 23.42 176.92 201.08 335.16 52.51 31.04 Other Current Assets 60.14 9.46 116.72 105.80 392.69 294.41 194.12 205.73 102.06 105.21 Short Term Loans & Adv. 40.31 198.36 267.62 273.26 378.34 278.33 184.86 201.40 96.97 101.66 Net Current Assets -1,333.57 -661.58 -86.42 155.46 -2,104.61 -297.76 -463.11 729.49 740.34 590.36 Total Assets 3,125.36 3,358.00 3,862.07 4,061.39 4,651.04 3,938.12 3,910.24 3,773.56 4,233.96 3,484.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Cash From Operating Activity 5.58 317.68 211.30 -369.72 174.91 763.90 312.12 -40.28 34.80 216.39 PBT -401.47 -445.42 -291.52 -237.53 -543.52 79.74 173.80 460.05 -36.85 238.54 Adjustment 449.77 575.53 495.56 999.29 709.11 265.55 249.03 -525.37 219.11 159.23 Changes in Working Capital -35.68 187.56 7.26 -668.57 9.33 447.41 -49.55 90.93 -144.72 -149.20 Cash after chg. in Working capital 12.62 317.68 211.30 93.18 174.91 792.70 373.28 25.61 37.54 248.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.04 0.00 0.00 -47.03 0.00 -28.80 -61.17 -65.89 -2.75 -32.19 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -415.87 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -27.95 -8.62 -1.23 1,334.21 -997.95 -309.20 -361.86 1,413.47 -466.26 -553.69 Net Fixed Assets 1,346.74 -7.97 -2.38 848.92 -751.02 -494.66 -121.72 428.65 -504.48 -594.63 Net Investments -0.11 -0.01 0.00 -0.47 24.72 -18.48 -6.85 -1.20 -8.55 1.89 Others -1,374.58 -0.64 1.15 485.76 -271.65 203.94 -233.29 986.02 46.77 39.05 Cash from Financing Activity 33.39 -366.12 -286.52 -597.32 675.85 -478.29 -72.95 -1,070.81 428.69 248.03 Net Cash Inflow / Outflow 11.02 -57.07 -76.45 367.17 -147.19 -23.59 -122.70 302.38 -2.78 -89.27 Opening Cash & Equivalents 19.58 313.11 389.57 22.40 169.59 193.18 315.88 13.50 16.28 105.56 Closing Cash & Equivalent 30.60 256.04 313.11 389.57 22.40 169.59 193.18 315.88 13.50 16.28

Description Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Cash From Operating Activity 9.18 317.01 212.20 -369.07 168.17 737.02 332.13 -34.32 45.90 210.29 PBT -398.96 -452.28 -296.18 -243.29 -572.51 75.44 171.57 469.83 -33.82 228.56 Adjustment 453.49 582.11 490.19 1,006.39 661.19 333.54 214.51 -557.33 199.78 132.43 Changes in Working Capital -38.31 187.17 18.19 -669.27 79.49 356.82 7.24 119.07 -117.26 -118.42 Cash after chg. in Working capital 16.22 317.01 212.20 93.84 168.17 765.80 393.31 31.57 48.71 242.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.04 0.00 0.00 -47.03 0.00 -28.78 -61.18 -65.89 -2.81 -32.28 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -415.87 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -28.06 -8.59 -1.46 1,333.66 -986.04 -293.05 -367.41 1,412.76 -476.97 -545.40 Net Fixed Assets 1,346.74 -7.97 -2.38 848.92 -751.02 -494.66 -121.72 428.65 -504.48 -594.63 Net Investments -0.11 -0.01 0.00 -0.47 24.72 -18.48 -6.85 -1.20 -8.55 1.89 Others -1,374.69 -0.61 0.92 485.21 -259.74 220.09 -238.84 985.31 36.06 47.34 Cash from Financing Activity 33.39 -366.30 -286.36 -597.44 664.38 -480.15 -77.75 -1,076.81 431.08 247.36 Net Cash Inflow / Outflow 14.51 -57.88 -75.62 367.14 -153.49 -36.17 -113.03 301.64 0.02 -87.75 Opening Cash & Equivalents 20.60 314.94 390.56 23.42 176.92 213.09 326.13 24.49 24.47 112.22 Closing Cash & Equivalent 35.11 257.06 314.94 390.56 23.42 176.92 213.09 326.13 24.49 24.47

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Book Value (Rs.) -75.78 -29.66 19.24 51.54 69.29 162.73 160.99 139.07 83.28 104.49 ROA -10.65% -13.03% -6.76% -4.30% -12.30% 2.65% 4.16% 8.27% -1.36% 5.83% ROE 0.00% 0.00% -89.85% -41.19% -64.88% 9.04% 15.09% 42.31% -8.19% 31.03% ROCE -3.40% -6.44% 0.08% 4.20% -0.68% 8.16% 9.93% 24.14% 4.06% 13.39% Fixed Asset Turnover 0.29 0.26 0.31 0.53 0.58 0.65 0.73 0.96 0.54 0.74 Receivable days 110.08 148.10 136.50 49.54 26.16 59.67 130.01 110.38 179.22 129.46 Inventory Days 107.53 97.12 92.83 77.61 106.90 125.50 106.71 92.00 208.84 180.35 Payable days 192.92 181.33 144.12 82.15 97.04 83.14 75.92 93.17 113.02 91.64 Cash Conversion Cycle 24.69 63.90 85.21 45.00 36.02 102.04 160.80 109.21 275.04 218.17 Total Debt/Equity -4.75 -11.77 18.78 7.31 6.56 1.74 1.82 1.68 4.43 2.84 Interest Cover -0.29 -0.61 0.01 0.29 -0.04 1.45 2.50 2.91 0.76 3.94

Description Mar 18 Mar 17 Mar 16 Mar 15 Sep 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Book Value (Rs.) -89.00 -43.58 5.51 38.63 53.94 160.74 151.79 133.11 78.11 100.98 ROA -10.88% -13.59% -7.05% -4.53% -13.04% 2.48% 4.07% 8.47% -1.27% 5.50% ROE 0.00% 0.00% -147.51% -55.58% -74.06% 8.86% 15.56% 45.60% -8.06% 30.49% ROCE -3.46% -6.93% -0.06% 4.17% -1.48% 8.12% 10.03% 24.70% 4.23% 13.02% Fixed Asset Turnover 0.29 0.27 0.29 0.52 0.57 0.66 0.73 0.94 0.55 0.72 Receivable days 85.57 115.97 116.98 45.27 27.22 60.58 126.84 108.66 168.81 128.10 Inventory Days 107.46 102.41 101.94 78.79 109.43 124.35 105.52 91.80 197.67 175.34 Payable days 198.57 186.30 148.72 86.46 100.90 89.04 77.18 87.92 107.36 90.80 Cash Conversion Cycle -5.54 32.07 70.20 37.60 35.76 95.89 155.18 112.54 259.12 212.65 Total Debt/Equity -4.04 -8.01 65.54 9.75 8.43 1.77 1.94 1.77 4.75 2.96 Interest Cover -0.29 -0.63 -0.01 0.28 -0.10 1.42 2.47 2.94 0.78 3.79

Top Investors:

life insurance corporation of india

limited liability partnership

Annual Reports:

News Update:

Orchid Pharma - Quarterly Results
12th Aug 2019, 17:57 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback